CYTOKINETICS, INCORPORATED Accrued Liabilities, Current
CYTOKINETICS, INCORPORATED (CYTK) had Accrued Liabilities, Current of $76.86 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $76.86M.
- 2026-03-31: Accrued Liabilities, Current $68.86M.
- 2025-12-31: Accrued Liabilities, Current $83.28M.
- 2025-09-30: Accrued Liabilities, Current $61.63M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $76.86M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $68.86M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $83.28M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $61.63M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $52.31M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $43.36M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $55.32M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $49.83M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $39.81M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $40.12M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $42.64M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $32.95M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $31.47M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $35.63M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $44.10M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $40.23M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $36.70M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $29.48M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $34.37M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $31.77M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $22.39M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $14.81M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $19.32M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $14.49M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $13.69M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $9.68M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $12.12M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $13.14M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $11.83M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $12.94M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $15.76M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $15.65M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $16.09M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $15.54M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $17.39M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $18.45M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $13.54M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $17.50M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $18.05M 10-K · filed 2018-03-05 | |
| 2016-09-30 | $16.31M 10-Q/A · filed 2016-12-15 | $17.78M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $9.50M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $7.88M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $8.42M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $6.76M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $6.43M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $3.98M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $5.40M 10-K · filed 2016-03-03 | |
| 2014-09-30 | $6.01M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $6.91M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $7.68M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $8.27M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $9.89M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $6.71M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $4.69M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $4.88M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $2.94M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $2.94M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $3.54M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $3.23M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $3.26M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $3.74M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $5.37M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |